Development services for minimally invasive glaucoma surgery (MIGS) device

Description

We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.

Oppdragsgivere

• Inven2 AS

Place of performance

• Oslo

All notice data

id:

2026-114934

eFormId:

74735805-a160-4bee-8396-70ffcde159c2

procedureId:

e42c1ba2-bf6c-4de9-b1f9-6aed5fa1a69b

heading:

Development services for minimally invasive glaucoma surgery (MIGS) device

description:

We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.

buyer:

1 results

1. id:

   995495899

   name:

   Inven2 AS

locationId:

1 results

1. NO081

placeOfPerformance:

• Oslo

issueDate:

2026-09-23T07:57:01Z

deadline:

not reported by source

qualificationDeadline:

not reported by source

noticeType:

ANNOUNCEMENT_OF_CONCLUSION_OF_CONTRACT

allTypes:

2 results

1. ANNOUNCEMENT_OF_CONCLUSION_OF_CONTRACT
2. RESULT

allCpvCodes:

5 results

1. 73000000
2. 33000000
3. 33122000
4. 33100000
5. 33120000

directCpvCodes:

3 results

1. 73000000
2. 33000000
3. 33122000

parentCpvCodes:

2 results

1. 33100000
2. 33120000

noticeStatus:

not reported by source

allReceivedTenders:

2 results

1. type:

   tenders

   total:

   0

2. type:

   t-esubm

   total:

   1

preferredPublicationDateTed:

not reported by source

plannedDateTed:

not reported by source

competitionDocsUrl:

not reported by source

sentToTed:

yes

regulationUrl:

https://lovdata.no/dokument/SF/forskrift/2016-08-12-974?q=foa

core:

estimatedValue:

amount:

3000000.0

code:

NOK

fullLocalizedText:

3000000.0 NOK

mainActivity:

gen-pub

awardedNames:

• Fearsome Ltd

changeNotices:

not reported by source

limitedDataFlag:

no

publicationDate:

2026-09-24

tedId:

657135-2026

procurementTimeline:

1 results

1. id:

   2026-114934

   allType:

   2 results

   1. ANNOUNCEMENT_OF_CONCLUSION_OF_CONTRACT
   2. RESULT

   publicationDate:

   2026-09-24

   selectedNotice:

   yes

procurementStrategicLabels:

No results.

lotsNumber:

1

doffin_url:

https://doffin.no/notices/2026-114934